The U.S. Food and Drug Administration (FDA) has approved niraparib (Zejula) plus Akeega (abiraterone acetate) and prednisone ...

Most premenopausal women with early breast cancer accepted GnRHa therapy during chemotherapy to preserve ovarian function, ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

The YES intervention improved general and cancer-specific quality of life in AYA breast cancer survivors over six months.

For 15 years, Suleika Jaouad has reported from the front lines of cancer treatment. Jaouad, the Emmy-winning journalist and author of “Between Two Kingdoms” and “The Book of Alchemy,” received her ...

Real and sham acupuncture were both linked to clinically meaningful and lasting improvements in perceived cognitive impairment compared with usual care for breast cancer survivors, but real ...

U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma, by Bristol ...